Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical

Prabu Manoharan1, Kiranmai Chennoju, Nanda Ghoshal

  • 1Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India. nghoshal@iicb.res.in.

Summary

Researchers developed proteochemometric models to predict inhibitors for Beta-secretase 1 (BACE1), a key target in Alzheimer's disease (AD) drug discovery. These models effectively identify potential BACE1 inhibitors, aiding early-stage AD treatment research.